Prevention and therapy of graft-versus-host disease. Report from a work-shop
Ringdén, O.; Kersey, J.H.
Bone Marrow Transplantation 10 Suppl. 1: 22-24
1992
ISSN/ISBN: 0268-3369 PMID: 1355684 Document Number: 397420
Document emailed within 1 workday
Related Documents
Dean, R.M.; Bishop, M.R. 2003: Graft-versus-host disease: emerging concepts in prevention and therapy Current Hematology Reports 2(4): 287-294Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Via, C.S.; Rus, V.; Gately, M.K.; Finkelman, F.D. 1994: IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease Journal of Immunology 153(9): 4040-4047
Atkinson, K.; Storb, R.; Weiden, P.L.; Deeg, H.J.; Gerhard-Miller, L.; Thomas, E.D. 1980: In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance Journal of Immunology 124(4): 1808-1814
Herve, P. 1991: Perspectives in the prevention and treatment of acute graft versus host disease Bone Marrow Transplantation 7 Suppl. 2: 117-119
de Witte, T.; Janssen, J.; de Pauw, B.; Holdrinet, R.; Wessels, J.; Haanen, C. 1986: Prevention of graft-vs-host disease following allogeneic bone marrow transplantation Nederlands Tijdschrift Voor Geneeskunde 130(28): 1290-1291
Champlin, R.; Jansen, J.; Ho, W.; Gajewski, J.; Nimer, S.; Lee, K.; Territo, M.; Winston, D.; Tricot, G.; Reichert, T. 1991: Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia Transplantation Proceedings 23(1 Pt 2): 1695-1696
Slavin, S.; Or, R.; Cividalli, G.; Brautbar, C.; Hale, G.; Waldmann, H.; Rachmilewitz, E. 1988: Bone marrow transplantation in beta-thalassemia major with prevention of graft-vs-host disease Birth Defects Original Article Series 23(5b): 313-316
Devergie, A.; Esperou, H.; Traineau, R.; Varrin, F.; Lehn, P.; Gluckman, E. 1989: Role of immunosuppressive drugs for prevention of graft-v-host disease after bone marrow transplantation Nouvelle Revue Francaise d'Hematologie 31(2): 73-75
Kren, V.; Otová, B.; Elleder, D.; Elleder, M.; Panczak, A.; Holý, A. 1993: Prevention of acute graft-versus-host disease in rats using 9-(2-phosphonomethoxyethyl) adenine (PMEA) Folia Biologica 39(2): 78-86
Tanaka, S. 1997: Prevention of post-transfusion graft versus host disease by irradiating blood products with X-ray or gamma-ray Nihon Rinsho. Japanese Journal of Clinical Medicine 55(9): 2277-2281
García-F-Villalta, Mía.J.; Pascual-López, M.; Elices, M.; Daudén, E.; García-Diez, A.; Fraga, J. 2002: Superficial mucoceles and lichenoid graft versus host disease: report of three cases Acta Dermato-Venereologica 82(6): 453-455
Otori, K.; Masuda, C.; Wanibuchi, H.; Nakanishi, A.; Kawabata, K.; Ohashi, H.; Fukushima, S. 1999: An autopsy report of graft-versus-host disease (GVHD) following blood transfusion Osaka City Medical Journal 45(1): 37-43
Cooper, M.H.; Markus, P.M.; Cai, X.; Starzl, T.E.; Fung, J.J. 1991: Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506 Transplantation Proceedings 23(6): 3238-3239
Cahn, J.Y.; Hervé, P.; Flesch, M.; Plouvier, E.; Racadot, E.; Montcuquet, P.; Noir, A.; Peters, A.; Leconte des Floris, R. 1986: T immunodepletion of the graft in allogeneic bone marrow grafts. Efficacy in the prevention of graft-versus-host reaction Presse Medicale 15(25): 1204
Shaffer, D.; Simpson, M.A.; Milford, E.L.; Gottschalk, R.; Kut, J.P.; Maki, T.; Monaco, A.P. 1991: Donor pretreatment with monoclonal antibody for prevention of graft-versus-host disease following small bowel transplantation: effect of depletion of T-cell subsets Transplantation Proceedings 23(1 Pt 1): 679-681
Mixon, B.; Mixon, J.; Isbey, E.K.; Sprinkle, S. 2014: Autologous serum eye drops for severe dry eye syndrome in a patient with chronic graft-versus-host disease: a case report International Journal of Pharmaceutical Compounding 18(5): 370-377
Frezza, E.E.; Gerunda, G.E.; Fassina, A.; DeFranchis, R.; Biffi, R.; Gurakar, A.; Fagiuoli, S.; Maffei, F.A.; Van Thiel, D.H. 1994: NK activity during graft-vs-host disease and graft rejection in rats following intestinal transplantation Transplantation Proceedings 26(3): 1626